Form 4: EverQuote Director George Neble Sells 2,500 Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Director George Neble of EverQuote, Inc. executed a sale of 2,500 shares of Class A Common Stock at an average price of $19.42, pursuant to a pre-arranged Rule 10b5-1 trading plan.
Summary
- On October 10, 2024, George Neble, a director of EverQuote, Inc., sold 2,500 shares of Class A Common Stock.
- The sale was executed under a Rule 10b5-1 trading plan adopted on June 11, 2024.
- The shares were sold at a weighted average price of $19.42, with individual transaction prices ranging from $19.12 to $19.68.
- Following the transaction, Neble directly owns 54,970 shares of EverQuote, Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged trading plan and doesn't necessarily reflect a change in the director's confidence in the company.
Industry Context
Sales by company insiders are a common occurrence and are often viewed in the context of overall company performance and insider sentiment. Rule 10b5-1 plans allow insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information.
Stakeholder Impact
- The sale of shares by a director could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 trading plan mitigates potential concerns.
Key Dates
| Date | Description |
|---|---|
| June 11, 2024 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| October 10, 2024 | Date of the transaction (sale of shares) |
| October 11, 2024 | Date of the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.